HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


HBW Podcasts

Listen to HBW Insight podcasts for our perspectives on regulation, policy, quality, R&D and key commercial topics.

Over The Counter 6 Jan 2023: Prebiotics And Consumer Health: Opportunity, Regulation and Future, With Clasado’s Per Rehné

In this episode, HBW Insight interviews Per Rehné, CEO of UK-based microbiome specialists Clasado Biosciences, about the exciting world of prebiotics. Essentially food for your gut microbiome, prebiotics have benefitted from a worldwide boom in preventative health in recent years, as well as a critical mass of clinical research showing the significant role that the gut plays in health, immunity and even stress and anxiety. In this fascinating discussion, Rehné explains the science behind prebiotic supplementation, as well as the regulatory environment in the European Union that makes marketing such supplements challenging, to say the least. We also dive into the current and future growth and innovation opportunities that prebiotics represent for the consumer health industry, which Clasado supplies, as well as marketing its own Bimuno branded product in the UK and beyond.

Over The Counter 1 Feb 2023: Biotech Is Solving Beauty’s Eco Challenges, Elevating R&D, With Amyris’ Annie Tsong

In this "Over the Counter" episode, HBW Insight chats with Annie Tsong, chief strategy and product officer at Amyris, Inc., an Emeryville, Calif.-based company that uses synthetic biotechnology to produce clean beauty, personal care, wellness and food ingredients for thousands of brands across the globe, including its own. Leading the firm’s ingredient development pipeline, Tsong discusses the science as well as the benefits of biotech alternatives to traditional beauty ingredients – including sustainability and better performance – and reflects on how the science is already transforming the beauty landscape.

Over The Counter 19 December 2022: CLP, Cosmetics And New Hazard Classes In The EU’s Haste To Be Green, With Louise Witter

In this episode, HBW Insight chats with Louise Witter, director and principal consultant at UK-based Chemical Legislation Professionals, about proposed revisions to the EU’s Classification, Labeling and Packaging Regulation (CLP) to introduce new hazard classes, including for endocrine disruptors. The discussion, just prior to the Commission’s adoption of the proposal on 19 December, ranges from implications for cosmetics companies to reflections on the EU Green Deal, which may be outpacing scientific consensus and endangering an already beleaguered and highly regulated chemicals industry.     

Over The Counter 13 Oct 2022: What To Expect From GSCF’s World Congress, With Judy Stenmark and Nicola Brink

In this episode, HBW Insight previews the upcoming Global Self-Care Federation World Congress, which will take place from 19-20 October in Cape Town, South Africa. We find out about what’s on the conference agenda from GSCF director general Judy Stenmark, and what the location means to local industry from the Self-Care Association of South Africa's CEO Nicola Brink.

Over The Counter 5 Sept 2022: Self-Care Regulation After COVID, With Haleon/GSCF’s Ian Urquhart

In this episode, HBW Insight talks to Haleon’s global head of regulatory intelligence and policy, Ian Urquhart, about the innovative and flexible approaches that regulators took to ensuring access to medicines during the coronavirus pandemic. Urquhart speaks about his work with the Global Self-Care Federation, where the regulatory affairs committee which he chairs has been looking into what happened during the pandemic and drawing lessons for the future. Strengthening supply chains, Rx-to-OTC switch and e-commerce are all on the agenda for the organization, which has published a series of papers in these areas to inform future self-care policy and regulation across the world.

Over The Counter 22 Aug 2022: Psychedelic Mushrooms With Alkemist Lab CEO Elan Sudberg

In this episode, HBW Insight speaks to Elan Sudberg, CEO of Alkemist Labs and chair of the American Herbal Product Association’s Psychedelic Plants and Fungi committee. Sudberg talks about the founding of the committee and the regulatory hoops that companies will have to jump through to research and develop psychedelic supplements, as well as the benefits that psychedelic plants are thought to have on human health.

Over The Counter 8 Aug 2022: The ‘Dos and Don’ts’ Of EU Supplement Innovation, With Mihai Inceu

In this episode, HBW Insight talks to regulatory expert Mihai Inceu about the challenges of innovating in Europe’s thriving food supplements market. Senior regulatory affairs officer at consultancy firm JensonR+, Inceu highlights some of the issues companies face in putting new wellness products onto the European market, particularly if they want to make health claims for herbal ingredients, also known as botanicals. As well as giving good advice about how to avoid getting into trouble with regulators, Inceu also points to some of the latest trends in this dynamic consumer health space.

CPHI Podcast Special: The Supplements Market – From Slump to Surge

In this podcast special, HBW Insight senior editor David Ridley is interviewed by CPHI's Rebecca Lumley about the latest trends in the European dietary supplements space. They discuss which products surged in popularity during the pandemic, the rise of self-care and the current regulatory environment in Europe.

See All


Pharma Intelligence podcasts discuss key ideas and insights affecting biopharma and medtech, brought to you by our global team of editors. Listen on-demand to our perspectives on the latest industry developments.



HBW Podcasts